← My Government dashboard

Government Watch

Dossier Legislative introduced 15-jul-2026
Bill introduced in Congress — not yet passed by either chamber, and not law.

Pharmaceutical Investment Oversight and Accountability Act

Key claim: The Pharmaceutical Investment Oversight and Accountability Act (S4987) would create federal oversight and accountability requirements for pharmaceutical-sector investments.

Abstract

(S4987 · 119th Congress) Latest action (2026-07-15): Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.

Why this matters

If enacted, this bill would extend federal financial oversight into pharmaceutical-sector investments, a novel intersection of securities/banking regulation and healthcare industrial policy. At introduction stage, however, the substantive obligations for investors, banks, or pharmaceutical firms remain unknown pending release of legislative text.

Source

Link

Briefing card

Pharmaceutical Investment Oversight and Accountability Act
Stage: introduced · congress · 15-jul-2026

The Pharmaceutical Investment Oversight and Accountability Act (S4987) would create federal oversight and accountability requirements for pharmaceutical-sector investments.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: congress:119-s-4987:introduced

Ask about this finding

Replies are grounded in the abstract and metadata above. The model will quote directly when possible and say so if a question isn't covered.

Stages other doctrine resolution introduced proposed rule passed chamber executive action final rule enacted district opinion circuit opinion opinion

Subscribe: calendar of upcoming dates · deadlines feed · all new records

build build 392 · ea9c128-dirty · 2026-08-09